Examkin

Soru

Zorluk: Çok zorPharmacologic Interventions

A 36-year-old man with recently diagnosed, untreated HIV infection is admitted to the hospital due to a 3-week history of progressively worsening headaches, nausea, and intermittent confusion. His CD4 cell count is 28 cells/mm328 \text{ cells/mm}^3. Vital signs show a temperature of 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), blood pressure of 118/76 mmHg118/76 \text{ mmHg}, heart rate of 92/min92/\text{min}, and respiratory rate of 14/min14/\text{min}. Neurologic examination is notable for lethargy and mild nuchal rigidity. A lumbar puncture is performed, revealing an opening pressure of 290 mm H2O290 \text{ mm H}_2\text{O}. Cerebrospinal fluid analysis shows a positive cryptococcal antigen test and the presence of encapsulated yeast on India ink preparation. The patient is to be treated with a comprehensive pharmacologic regimen to manage his opportunistic infection and underlying HIV.

Arrange the following pharmacologic interventions in the most appropriate chronological order of their initiation for this patient.

  1. 1Initiation of intravenous liposomal amphotericin B and oral flucytosine
  2. 2Initiation of oral fluconazole 400 mg daily
  3. 3Initiation of combination antiretroviral therapy (cART)
  4. 4Initiation of maintenance therapy with oral fluconazole 200 mg daily

Cevap

The correct chronological sequence of initiation is: 1) Intravenous liposomal amphotericin B and oral flucytosine, 2) Oral fluconazole 400 mg daily, 3) Combination antiretroviral therapy (cART), and 4) Maintenance therapy with oral fluconazole 200 mg daily.
The appropriate sequence strictly follows the established treatment protocol for HIV-associated cryptococcal meningitis. Management begins with a 2-week induction phase using fungicidal intravenous liposomal amphotericin B and oral flucytosine to achieve rapid clinical stabilization and cerebrospinal fluid sterilization. This is followed by an 8-week consolidation phase using high-dose oral fluconazole (400 mg daily). Crucially, combination antiretroviral therapy (cART) is delayed and typically initiated 4 to 6 weeks into antifungal treatment (during the consolidation phase) to mitigate the high risk of fatal Immune Reconstitution Inflammatory Syndrome (IRIS). Finally, upon completion of the consolidation phase, the patient is transitioned to maintenance therapy with low-dose oral fluconazole (200 mg daily) for at least one year.

Adım Adım Çözüm

1
Identify the primary diagnosis and required initial treatment phase.
The diagnosis is HIV-associated cryptococcal meningoencephalitis. The immediate requirement is induction therapy with intravenous liposomal amphotericin B and oral flucytosine.
Rapid fungicidal activity is critical to sterilize the cerebrospinal fluid and decrease mortality during the first 2 weeks.
2
Determine the subsequent phase of antifungal management.
After completing 2 weeks of induction, the regimen is switched to consolidation therapy with oral fluconazole 400 mg daily.
Consolidation therapy, lasting 8 weeks, prevents relapse while continuing to clear the fungal infection.
3
Establish the correct timing for starting antiretroviral therapy.
Combination antiretroviral therapy (cART) is initiated 4 to 6 weeks after the start of the initial antifungal therapy.
Intentionally delaying cART in cryptococcal meningitis minimizes the risk of severe Immune Reconstitution Inflammatory Syndrome (IRIS), which can dangerously increase intracranial pressure.
4
Identify the final long-term pharmacologic step.
Following 8 weeks of consolidation, the fluconazole dosage is reduced to 200 mg daily for maintenance therapy.
Maintenance therapy acts as secondary prophylaxis and must be continued for at least 1 year until the immune system sufficiently recovers.

Anahtar Kavram

The pharmacologic management of HIV-associated cryptococcal meningitis requires a three-phase antifungal regimen (induction, consolidation, maintenance) and a deliberate 4 to 6 week delay in initiating antiretroviral therapy to prevent potentially fatal Immune Reconstitution Inflammatory Syndrome (IRIS).
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru